Swift Biosciences Accel-NGS 2S Indexed Adaptors
Swift Biosciences has launched Accel-NGS 2S Indexed Adaptors, a set of 96 single indices that work in combination with Illumina TruSeq adaptors to provide up to 768 unique dual-index combinations. The kit will enable users to prepare up to 96 single-indexed samples and up to 768 dual-indexed samples per run. According to the company, the kit should help prevent misassignment and index hopping as well as enable detection of low-frequency variants.
ArcherDx VariantPlex Core Myeloid Panel
ArcherDx has launched the Archer VariantPlex Core Myeloid panel, a next-generation sequencing-based targeted panel that analyzes 37 genes related to myeloid malignancies. The company said the panel uses molecular barcoded reads, and can detect FLT3 internal tandem duplications, variants that are present in more than 20 percent of acute myeloid leukemia cases and are challenging to detect in NGS data. VariantPlex assays are provided in eight-strip, single-use lyophilized library preparation reagents that require no master mixes.
ArcherDx said that it also plans to launch a VariantPlex Myeloid panel, which expands the number of genes to 72.
Asuragen Expanded QuantideX qPCR BCR-ABL Portfolio
Asuragen has launched a new CE-marked QuantideX qPCR BCR-ABL minor kit for identifying minor (e1a2) BCR-ABL fusion transcripts in patients with chronic myeloid leukemia. The new test joins the firm's existing FDA-cleared and CE-marked QuantideX qPCR BCR-ABL IS Kit that covers major (e13a2, e14a2) fusions.
The two kits can be combined in a streamlined and common workflow, and Asuragen said it is also expanding the capabilities of its QuantideX Reporter, analysis software, which accompanies the CE-marked QuantideX qPCR BCR-ABL IS Kit, to allow laboratories the ability to report CML patient disease burden on the International Scale after reviewing ABL1 copy number, in compliance with European LeukemiaNet guidelines.
For more new products and services, please visit the New Products page on our website.